John M. Clancy

436 total citations
12 papers, 358 citations indexed

About

John M. Clancy is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, John M. Clancy has authored 12 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in John M. Clancy's work include Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). John M. Clancy is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). John M. Clancy collaborates with scholars based in Ireland, Canada and Portugal. John M. Clancy's co-authors include John F. Gilmer, Ana Luı́sa Simplı́cio, Andrew McVicar, Michael Jones, Pedro M. Matias, Neil Frankish, Helen Sheridan, Maria José Santos-Martínez, Carlos Medina and V.R. Holland and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Molecules.

In The Last Decade

John M. Clancy

12 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Clancy Ireland 11 121 116 75 52 31 12 358
Dorota Żelaszczyk Poland 11 216 1.8× 74 0.6× 53 0.7× 55 1.1× 33 1.1× 40 455
Tae Woo Kim South Korea 11 145 1.2× 224 1.9× 36 0.5× 27 0.5× 15 0.5× 25 443
Jorge Heredia‐Moya Ecuador 13 96 0.8× 192 1.7× 55 0.7× 59 1.1× 21 0.7× 43 478
Tzenge‐Lien Shih Taiwan 15 175 1.4× 307 2.6× 62 0.8× 41 0.8× 18 0.6× 58 578
Lixiang Ren China 10 244 2.0× 130 1.1× 55 0.7× 28 0.5× 21 0.7× 13 614
Yu. A. Kim Russia 11 212 1.8× 66 0.6× 23 0.3× 68 1.3× 25 0.8× 37 487
Magdy N. Iskander Australia 11 169 1.4× 141 1.2× 15 0.2× 45 0.9× 16 0.5× 32 395
V.R. Holland United Kingdom 7 97 0.8× 72 0.6× 71 0.9× 20 0.4× 45 1.5× 13 327
Mohamed Moalin Netherlands 12 95 0.8× 152 1.3× 20 0.3× 41 0.8× 19 0.6× 18 383
Nicola Gaggelli Italy 12 198 1.6× 66 0.6× 27 0.4× 37 0.7× 31 1.0× 37 448

Countries citing papers authored by John M. Clancy

Since Specialization
Citations

This map shows the geographic impact of John M. Clancy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Clancy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Clancy more than expected).

Fields of papers citing papers by John M. Clancy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Clancy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Clancy. The network helps show where John M. Clancy may publish in the future.

Co-authorship network of co-authors of John M. Clancy

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Clancy. A scholar is included among the top collaborators of John M. Clancy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Clancy. John M. Clancy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jones, Michael, Carlos Medina, Maria José Santos-Martínez, et al.. (2009). Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups. Journal of Medicinal Chemistry. 52(21). 6588–6598. 24 indexed citations
2.
Simplı́cio, Ana Luı́sa, John M. Clancy, & John F. Gilmer. (2008). Prodrugs for Amines. Molecules. 13(3). 519–547. 103 indexed citations
3.
Jones, Michael, et al.. (2008). Discovery of a “True” Aspirin Prodrug. Journal of Medicinal Chemistry. 51(24). 7991–7999. 22 indexed citations
4.
Gilmer, John F., et al.. (2007). Evaluation of nitrate-substituted pseudocholine esters of aspirin as potential nitro-aspirins. Bioorganic & Medicinal Chemistry Letters. 17(11). 3217–3220. 10 indexed citations
5.
Clancy, John M. & Andrew McVicar. (2007). Handbook of Chemical and Biological Warfare Agents. 77 indexed citations
6.
Simplı́cio, Ana Luı́sa, John M. Clancy, & John F. Gilmer. (2006). β-Aminoketones as prodrugs with pH-controlled activation. International Journal of Pharmaceutics. 336(2). 208–214. 29 indexed citations
7.
Simplı́cio, Ana Luı́sa, Pedro M. Matias, John F. Gilmer, & John M. Clancy. (2006). Chiral separation and identification of β-aminoketones of pharmacological interest by high performance liquid chromatography and capillary electrophoresis. Journal of Chromatography A. 1120(1-2). 89–93. 10 indexed citations
8.
Gilmer, John F., Ana Luı́sa Simplı́cio, & John M. Clancy. (2005). A new amino-masking group capable of pH-triggered amino-drug release. European Journal of Pharmaceutical Sciences. 24(4). 315–323. 9 indexed citations
9.
Simplı́cio, Ana Luı́sa, John F. Gilmer, Neil Frankish, et al.. (2004). Ionisation characteristics and elimination rates of some aminoindanones determined by capillary electrophoresis. Journal of Chromatography A. 1045(1-2). 233–238. 10 indexed citations
10.
Gilmer, John F., et al.. (2003). Single oral dose study of two isosorbide-based aspirin prodrugs in the dog. Journal of Pharmacy and Pharmacology. 55(10). 1351–1357. 12 indexed citations
11.
Gilmer, John F., et al.. (2002). Isosorbide-based aspirin prodrugs. European Journal of Pharmaceutical Sciences. 16(4-5). 297–304. 32 indexed citations
12.
Gilmer, John F., et al.. (2001). Synthesis, hydrolysis kinetics and anti-platelet effects of isosorbide mononitrate derivatives of aspirin. European Journal of Pharmaceutical Sciences. 14(3). 221–227. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026